These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32125662)

  • 1. Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Cholangiocarcinoma.
    Mastoraki A; Schizas D; Charalampakis N; Naar L; Ioannidi M; Tsilimigras D; Sotiropoulou M; Moris D; Vassiliu P; Felekouras E
    Mol Diagn Ther; 2020 Apr; 24(2):175-184. PubMed ID: 32125662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma - cell line findings.
    Sriraksa R; Limpaiboon T
    Asian Pac J Cancer Prev; 2013; 14(4):2503-8. PubMed ID: 23725164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors.
    He JC; Yao W; Wang JM; Schemmer P; Yang Y; Liu Y; Qian YW; Qi WP; Zhang J; Shen Q; Yang T
    Oncotarget; 2016 Nov; 7(46):75441-75456. PubMed ID: 27705912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition.
    Yin Y; Zhang M; Dorfman RG; Li Y; Zhao Z; Pan Y; Zhou Q; Huang S; Zhao S; Yao Y; Zou X
    Cell Death Dis; 2017 Jun; 8(6):e2856. PubMed ID: 28569784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Synergistic Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Sarcoma.
    Mastoraki A; Schizas D; Vlachou P; Melissaridou NM; Charalampakis N; Fioretzaki R; Kole C; Savvidou O; Vassiliu P; Pikoulis E
    Mol Diagn Ther; 2020 Oct; 24(5):557-569. PubMed ID: 32696211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer.
    Thurn KT; Thomas S; Moore A; Munster PN
    Future Oncol; 2011 Feb; 7(2):263-83. PubMed ID: 21345145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment.
    Schizas D; Mastoraki A; Naar L; Spartalis E; Tsilimigras DI; Karachaliou GS; Bagias G; Moris D
    World J Gastroenterol; 2018 Nov; 24(41):4635-4642. PubMed ID: 30416311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma.
    Pant K; Peixoto E; Richard S; Gradilone SA
    Cells; 2020 Mar; 9(3):. PubMed ID: 32210140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.
    Damaskos C; Garmpis N; Valsami S; Kontos M; Spartalis E; Kalampokas T; Kalampokas E; Athanasiou A; Moris D; Daskalopoulou A; Davakis S; Tsourouflis G; Kontzoglou K; Perrea D; Nikiteas N; Dimitroulis D
    Anticancer Res; 2017 Jan; 37(1):35-46. PubMed ID: 28011471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical development of histone deacetylase inhibitors as targeted anticancer drugs.
    Marks PA
    Expert Opin Investig Drugs; 2010 Sep; 19(9):1049-66. PubMed ID: 20687783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone Deacetylases (HDACs) in Gastric Cancer: An Update of their Emerging Prognostic and Therapeutic Role.
    Schizas D; Mastoraki A; Naar L; Tsilimigras DI; Katsaros I; Fragkiadaki V; Karachaliou GS; Arkadopoulos N; Liakakos T; Moris D
    Curr Med Chem; 2020; 27(36):6099-6111. PubMed ID: 31309879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic effects of DNA-targeted chemotherapeutics and histone deacetylase inhibitors as therapeutic strategies for cancer treatment.
    Stiborová M; Eckschlager T; Poljaková J; Hraběta J; Adam V; Kizek R; Frei E
    Curr Med Chem; 2012; 19(25):4218-38. PubMed ID: 22680633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical management of cholangiocarcinomas in 2015].
    Marret G; Neuzillet C; Rousseau B; Tournigand C
    Bull Cancer; 2016 Apr; 103(4):389-99. PubMed ID: 26922666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents.
    Hanikoglu A; Hanikoglu F; Ozben T
    Curr Protein Pept Sci; 2018; 19(3):333-340. PubMed ID: 28059044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM; Roth DM; Marchal C; Bouchecareilh M
    Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer.
    Bai Y; Ahmad D; Wang T; Cui G; Li W
    Curr Top Med Chem; 2019; 19(12):995-1004. PubMed ID: 30686256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Antiangiogenesis Role of Histone Deacetylase Inhibitors: Their Potential Application to Tumor Therapy and Tissue Repair.
    Deng B; Luo Q; Halim A; Liu Q; Zhang B; Song G
    DNA Cell Biol; 2020 Feb; 39(2):167-176. PubMed ID: 31808715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment for cholangiocarcinoma.
    Adeva J; Sangro B; Salati M; Edeline J; La Casta A; Bittoni A; Berardi R; Bruix J; Valle JW
    Liver Int; 2019 May; 39 Suppl 1():123-142. PubMed ID: 30892822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathways and targeted therapy in cholangiocarcinoma.
    Dabney RS; Khalife M; Shahid K; Phan AT
    Clin Adv Hematol Oncol; 2019 Nov; 17(11):630-637. PubMed ID: 31851165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histones and lung cancer: Are the histone deacetylases a promising therapeutic target?
    Petta V; Gkiozos I; Strimpakos A; Syrigos K
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):935-52. PubMed ID: 24036844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.